Comparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture. [electronic resource]
Producer: 20150330Description: 1593-8 p. digitalISSN:- 1435-702X
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Bevacizumab
- Choroid -- drug effects
- Enzyme-Linked Immunosorbent Assay
- Organ Culture Techniques
- Ranibizumab
- Receptors, Vascular Endothelial Growth Factor -- pharmacology
- Recombinant Fusion Proteins -- pharmacology
- Retinal Pigment Epithelium -- drug effects
- Swine
- Time Factors
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.